TTY Biopharm and Taiho Pharmaceutical entered in an exclusive agreement of an effective anticancer drug; LONSURF® has received license approval for treatment of metastatic colorectal cancer from TFDA.
The former Chairman of TTY Biopharm, Mr. Rongjin Lin has been sentenced with an execution of ten years in prison, and the confiscation of illegal earnings.
MolMed and TTY Biopharm entered into an exclusive agreement to commercialise Zalmoxis® in certain Asian territories
MolMed and TTY Biopharm entered into a term sheet to commercialise Zalmoxis® in certain Asian territories
Overcame Barriers - Anticancer Agent S-1 Capsule (S-1) Received Reimbursement for Adjuvant Treatment of Locally-advanced Gastric Cancer
TTY Biopharm’s Anticancer Agent S-1 Received Reimbursement for Adjuvant Treatment of Locally-advanced Gastric Cancer
TTY Biopharm received an exclusive license from Taiho Pharmaceutical to sell trifluridine/tipiracil, a new and effective anticancer drug, in Taiwan market
TTY Biopharm (4105 TT) and PharmaMar (MSE:PHM) jointly announce that PharmaMar submits MAA to EMA for Aplidin ® (New chemical entity) for the treatment of MM
Overview of Drug Evaluation and Registration
TTY and the international company will jointly develop the overseas market for the Liposome product